Literature DB >> 1530082

Possible clozapine exacerbation of bulimia nervosa.

T D Brewerton, M Shannon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1530082     DOI： 10.1176/ajp.149.10.1408

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders.

Authors:  S Gebhardt; M Haberhausen; J-C Krieg; H Remschmidt; M Heinzel-Gutenbrunner; J Hebebrand; F M Theisen
Journal:  J Neural Transm (Vienna)       Date:  2007-03-20       Impact factor: 3.575

Review 2.  Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Francisco Romo-Nava
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

3.  Pharmacological management of binge eating disorder: current and emerging treatment options.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Anne M O'Melia
Journal:  Ther Clin Risk Manag       Date:  2012-05-08       Impact factor: 2.423

4.  Psychotropic drug prescribing in an Australian specialist child and adolescent eating disorder service: a retrospective study.

Authors:  Julia K Moore; Hunna J Watson; Emily Harper; Julie McCormack; Thinh Nguyen
Journal:  J Eat Disord       Date:  2013-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.